심장 모니터링 및 심장박동관리 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report By Product (Cardiac Monitoring Devices), By End-use (Hospitals, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

심장 모니터링 및 심장박동관리 기기 시장의 성장 및 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 심장 모니터링 및 심장박동관리 기기 시장 규모는 2025-2030년 동안 7.3%의 CAGR을 기록하며 2030년까지 332억 9,000만 달러에 달할 것으로 예상됩니다. 심혈관질환의 발생률 증가와 의료기기의 발전이 시장을 주도하고 있습니다.

허혈성 심장병과 같은 심혈관질환은 전 세계적으로 주요 사망 원인 중 하나이며, CDC에 따르면 심혈관질환의 유병률과 사망자 수는 안정적으로 유지되고 있으며, 2017년에는 인구의 거의 31.0%가 심혈관질환으로 인해 사망했습니다. 또한, 지난 몇 년 동안 비만 발생률이 증가하고 있으며, 미국 성인의 37.7%가 비만인 것으로 추정됩니다. 또한 2016년 미국 성인의 약 18.0%가 고비중 지단백 콜레스테롤 수치가 40mg/dL 이하인 것으로 나타났습니다. 산업계는 심혈관질환을 위한 첨단 의료기기를 개발하기 위해 노력하고 있으며, 이는 시장을 촉진하고 있습니다.

병원 부문은 2019년 수익 측면에서 가장 큰 시장 점유율을 차지했습니다. 병원은 문제를 효율적으로 모니터링하고 조기에 진단하여 심혈관질환을 앓고 있는 환자에게 최적의 치료를 제공할 수 있습니다. 이는 시장 내 해당 부문의 성장을 증가시킬 것으로 예상됩니다.

재택의료 부문은 치료의 용이성과 비용 효율성으로 인해 예측 기간 동안 큰 성장을 보일 것으로 예상됩니다. 원격지에서 심혈관질환을 모니터링하는 데 필요한 의료기기의 소형화는 향후 몇 년 동안 이 부문을 견인할 것으로 예상됩니다.

북미는 노인 인구의 증가로 인해 2019년에 가장 큰 매출 점유율을 차지했습니다. 또한, 소형화, 긴 배터리 수명, 생체적합성 재료의 사용 등 의료기기의 급속한 기술 발전도 이 지역의 시장 성장을 촉진하고 있습니다. 또한, 심부전 및 심폐정지를 포함한 심혈관질환의 증가는 이 지역의 시장 성장을 촉진할 것으로 예상됩니다.

아시아태평양에서는 예측 기간 동안 시장이 크게 성장할 것으로 예상됩니다. 이는 이 지역에서 양질의 의료 서비스에 대한 수요가 증가하고 있기 때문입니다. 인도, 일본, 중국을 포함한 여러 국가에서 고령화 인구가 증가함에 따라 이 지역의 첨단 의료기기에 대한 수요가 증가하고 있습니다.

심장 모니터링 및 심장박동관리 기기 시장 보고서 하이라이트

• 심혈관질환, 특히 부정맥과 심부전 유병률 증가로 인해 심장박동관리 기기 부문이 2024년 66.0%의 매출 점유율로 시장을 장악했습니다.
• 2024년 매출 점유율은 병원 부문이 가장 높았는데, 이는 복잡한 심장 질환을 가진 환자에게 종합적인 치료를 제공할 수 있는 병원 때문으로 분석됩니다.
• 북미 심장 모니터링 및 심장박동관리 기기 시장은 높은 의료 지출과 잘 정비된 의료 인프라로 인해 2024년 47.0%의 가장 높은 매출 점유율을 차지했습니다.
• 아시아태평양의 심장 모니터링 및 심장박동관리 기기 시장은 예측 기간 동안 8.1%의 CAGR을 기록할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 심장 모니터링 및 심장박동관리 기기 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 심장 모니터링 및 심장박동관리 기기 시장 : 제품 비즈니스 분석

• 제품 시장 점유율, 2024년과 2030년
• 제품 부문 대시보드
• 시장 규모와 예측과 동향 분석, 제품별, 2018-2030년
• 심장 모니터링 기기
• 심장박동관리 기기

제5장 심장 모니터링 및 심장박동관리 기기 시장 : 최종 용도 비즈니스 분석

• 최종 용도 시장 점유율, 2024년과 2030년
• 최종 용도 부문 대시보드
• 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
• 병원
• 외래 수술 센터
• 기타

제6장 심장 모니터링 및 심장박동관리 기기 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 참여자 개요
• 기업의 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 개요/상장 기업
  • Stryker
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • ZOLL Medical Corporation
  • GE HealthCare
  • MicroPort Scientific Corporation
  • NIHON KOHDEN CORPORATION
  • BioTelemetry

ksm

영문 목차

영문목차

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Growth & Trends:

The global cardiac monitoring and cardiac rhythm management devices market size is expected to reach USD 33.29 billion by 2030, registering a CAGR of 7.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of cardiovascular diseases and advancement in medical devices is driving the market.

Cardiovascular disorders, such as ischemic heart disease, are one of the leading causes of death globally. According to the CDC, the prevalence of cardiovascular diseases and the number of deaths has remained steady with almost 31.0% of the population dying due to such diseases in 2017. Moreover, the incidence of obesity has increased over the past few years; an estimated 37.7% of adults in the U.S. are obese. In addition, in 2016, about 18.0% of the U.S. adults had high-density lipoprotein cholesterol levels of less than 40 mg/dL. Industry players are trying to develop advanced medical devices for cardiovascular disorders, which is propelling the market.

The hospital segment held the largest market share in terms of revenue in 2019. Hospitals are able to provide optimal care of the patients suffering from cardiovascular disorders by efficiently monitoring and diagnosing the problem at an early stage. This, in turn, is anticipated to augment the growth of the segment in the market.

The home care segment is expected to witness significant growth over the forecast period owing to ease of treatment and cost-effectiveness provided by the system. Miniaturization of medical devices required to monitor cardiovascular events at remote places is anticipated to drive the driving segment in the coming years.

North America held the largest revenue share in 2019 owing to the increasing geriatric population in the region. In addition, rapid technological advancements in medical devices such as miniaturization, long battery life, the use of biocompatible materials are also stimulating the growth of the market in the region. Moreover, rising cases of cardiovascular disorders including heart failure and cardiovascular arrests are expected to propel market growth in the region.

In Asia Pacific, the market is anticipated to witness significant growth over the forecast period. This is attributed to the rising demand for quality healthcare services in the region. The growing number of an aging population in countries including India, Japan, and China is driving demand for advanced medical devices in the region.

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Report Highlights:

• The cardiac rhythm management devices segment dominated the market with a revenue share of 66.0% in 2024 due to the increasing prevalence of cardiovascular diseases, particularly arrhythmias and heart failure.
• The hospitals segment dominated the market with the largest revenue share in 2024, which can be attributed to their capability to provide comprehensive care for patients with complex cardiac conditions.
• North America cardiac monitoring and cardiac rhythm management devices market held the highest revenue share of 47.0% in 2024 due to substantial healthcare spending and a well-developed medical infrastructure.
• The Asia Pacific cardiac monitoring and cardiac rhythm management devices market is expected to register the highest CAGR of 8.1% over the forecast period, which can be attributed to rapid urbanization and a rise in lifestyle-related diseases.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Cardiac Monitoring and Cardiac Rhythm Management Devices Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Cardiac Monitoring Devices
  • 4.4.1. Cardiac Monitoring Devices Market, 2018 - 2030 (USD Million)
  • 4.4.2. ECG
    • 4.4.2.1. ECG Market, 2018 - 2030 (USD Million)
  • 4.4.3. Implantable Cardiac Monitors
    • 4.4.3.1. Implantable Cardiac Monitors Market, 2018 - 2030 (USD Million)
  • 4.4.4. Holter Monitors
    • 4.4.4.1. Holter Monitors Market, 2018 - 2030 (USD Million)
  • 4.4.5. Mobile Cardiac Telemetry
    • 4.4.5.1. Mobile Cardiac Telemetry Market, 2018 - 2030 (USD Million)
• 4.5. Cardiac Rhythm Management Devices
  • 4.5.1. Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
  • 4.5.2. Cardiac Resynchronization Therapy (CRT)
    • 4.5.2.1. Cardiac Resynchronization Therapy (CRT) Market, 2018 - 2030 (USD Million)
    • 4.5.2.2. CRT-Defibrillator
      • 4.5.2.2.1. CRT-Defibrillator Market, 2018 - 2030 (USD Million)
    • 4.5.2.3. CRT-Pacemakers
      • 4.5.2.3.1. CRT-Pacemakers Market, 2018 - 2030 (USD Million)
  • 4.5.3. Defibrillator
    • 4.5.3.1. Defibrillator Market, 2018 - 2030 (USD Million)
    • 4.5.3.2. Implantable Cardioverter Defibrillators (ICD)
      • 4.5.3.2.1. Implantable Cardioverter Defibrillators (ICD) Market, 2018 - 2030 (USD Million)
      • 4.5.3.2.2. Single Chamber
      • 4.5.3.2.3. Single Chamber Market, 2018 - 2030 (USD Million)
      • 4.5.3.2.4. Dual Chamber
      • 4.5.3.2.5. Dual Chamber Market, 2018 - 2030 (USD Million)
    • 4.5.3.3. External Defibrillator
      • 4.5.3.3.1. External Defibrillator Market, 2018 - 2030 (USD Million)
      • 4.5.3.3.2. Manual External Defibrillator
        • 4.5.3.3.2.1. Manual External Defibrillator Market, 2018 - 2030 (USD Million)
      • 4.5.3.3.3. Automatic External Defibrillator
        • 4.5.3.3.3.1. Automatic External Defibrillator Market, 2018 - 2030 (USD Million)
      • 4.5.3.3.4. Wearable Cardioverter Defibrillator
        • 4.5.3.3.4.1. Wearable Cardioverter Defibrillator Market, 2018 - 2030 (USD Million)
  • 4.5.4. Pacemakers
    • 4.5.4.1. Pacemakers Market, 2018 - 2030 (USD Million)
    • 4.5.4.2. Conventional
      • 4.5.4.2.1. Conventional Market, 2018 - 2030 (USD Million)
    • 4.5.4.3. Leadless
      • 4.5.4.3.1. Leadless Market, 2018 - 2030 (USD Million)

Chapter 5. Cardiac Monitoring and Cardiac Rhythm Management Devices Market: End Use Business Analysis

• 5.1. End Use Market Share, 2024 & 2030
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 5.5. Ambulatory Surgery Centers
  • 5.5.1. Ambulatory Surgery Centers Market, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Cardiac Monitoring and Cardiac Rhythm Management Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Canada Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Stryker
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Medtronic
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Abbott
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Boston Scientific Corporation
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Koninklijke Philips N.V.
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. ZOLL Medical Corporation.
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. GE HealthCare
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. MicroPort Scientific Corporation
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. NIHON KOHDEN CORPORATION
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. BioTelemetry
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives

관련자료